| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.49B | +12.0% |
| Cost of Revenue | $14.85B | +12.7% |
| Gross Profit | $813.0M | — |
| R&D Expense | $1.12B | +8.7% |
| SG&A Expense | $1.14B | +5.9% |
| Operating Income | $1.26B | +6.2% |
| Interest Expense | $219.0M | +46.0% |
| Pre-tax Income | $990.0M | +8.8% |
| Income Tax | $121.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.53B | -51.2% |
| Accounts Receivable | $3.43B | +23.3% |
| Inventory | $2.34B | +16.2% |
| Current Assets | $7.78B | -7.7% |
| Total Assets | $21.88B | +21.5% |
| Current Liabilities | $4.87B | +15.6% |
| Long-term Debt | $6.58B | +62.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.26B | +3.4% |
| Capital Expenditures | $844.0M | +38.1% |
| Investing Cash Flow | -$5.18B | -610.8% |
| Financing Cash Flow | $2.36B | +1335.1% |
| Free Cash Flow | $419.0M | -31.4% |
| +19.8% |
| Net Income | $594.0M | +0.7% |
| EPS (Basic) | $1.96 | +0.5% |
| EPS (Diluted) | $1.96 | +1.0% |
| Total Liabilities |
| $12.79B |
| +35.4% |
| Stockholders' Equity | $8.81B | +5.5% |